Rebecca Velez Frey

Rebecca Velez Frey

Geen lopende functies
52 jaar
Health Technology
Finance
Consumer Services

Profiel

Rebecca Velez Frey is currently President, Chief Executive Officer & Director and President & Chief Executive Officer at Yarrow Bioscience, Inc. since 2025.
Also holds positions on the Board of Directors at Halda Therapeutics LLC, Director at Siduma Therapeutics, Inc. since 2021, and Venture Partner at RTW Investments LP since 2025.
Formerly Associate Director at Novartis Inflammasome Research, Inc. from 2002 to 2006, Vice President at Alexion Pharmaceuticals, Inc. from 2012 to 2017, Chief Operating Officer at Cardurion Pharmaceuticals, Inc. from 2018 to 2020, Chief Operating Officer at Evolveimmune Therapeutics, Inc. from 2020 to 2021, and Venture Partner at Elm Street Advisors LLC from 2021 to 2025.
Earned a doctorate from Northeastern University in 1998.

Actieve functies van Rebecca Velez Frey

BedrijvenFunctieBegin
Directeur/Bestuurslid -
Directeur/Bestuurslid 01-12-2021
Private Equity Investor 01-02-2025

Eerdere bekende functies van Rebecca Velez Frey

BedrijvenFunctieEinde
Private Equity Investor 01-12-2025
Operationeel Directeur 31-12-2021
Operationeel Directeur 31-12-2020
ALEXION PHARMACEUTICALS, INC. President 30-09-2017
Directeur/Bestuurslid 30-09-2006
Ervaring van Rebecca Velez Frey in detail bekijken

Opleiding van Rebecca Velez Frey

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

88

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Rebecca Velez Frey